Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Research article

Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients

Authors: J. Ernst, A. Mehnert, A. Dietz, B. Hornemann, P. Esser

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

To date, research on stigmatization among cancer patients and related psychosocial consequences has been scarce and mostly based on small and highly selected samples. We investigated stigmatization and its impact on quality of life among a large sample including four major tumor entities.

Methods

We assessed 858 patients with breast, colon, lung or prostate cancer from two cancer registries. Stigmatization and quality of life (QoL) was assessed with the Social Impact Scale (SIS-D) and the EORTC Quality of Life Questionnaire (European Organization for Research and Treatment of Cancer), respectively. Group effects were analyzed via analyses of variance, relationships were investigated via Pearson’s r and stepwise regression analyses.

Results

The mean age was 60.7 years, 54% were male. Across cancer sites, the dimensions of stigmatization (isolation, social rejection, financial insecurity and internalized shame) were in the lower and middle range, with the highest values found for isolation. Stigmatization was lowest among prostate cancer patients. Stigmatization predicted all five areas of QoL among breast cancer patients (p < .05), but only affected emotional functioning (p < .01) among lung cancer patients.

Conclusions

We found an inverse relationship between perceived cancer-related stigmatization and various dimensions of QoL, with variation between cancer sites. Breast cancer patients should be focused in individual therapies regarding the negative consequences accompanied by perceived stigmatization.
Literature
1.
Goffman E. Stigma: notes on the Management of Spoiled Identity. Englewood Cliffs, NJ: Prentice Hall; 1963.
2.
Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27:363–85.CrossRef
3.
Kim MA, Yi J. Life after cancer: how does public stigma increase psychological distress of childhood cancer survivors? Int J Nurs Stud. 2014;51(12):1605–14.CrossRefPubMed
4.
Koller M, Kussman J, Lorenz W, Jenkins M, Voss M, Arens E, et al. Symptom reporting in cancer patients: the role of negative affect and experienced social stigma. Cancer. 1996;77(5):983–95.CrossRefPubMed
5.
Lebel S, Castonguay M, Mackness G, Irish J, Bezjak A, Devins GM. The psychosocial impact of stigma in people with head and neck or lung cancer. Psycho-Oncology. 2013;22(1):140–52.CrossRefPubMed
6.
Gonzalez BD, Jacobsen PB. Depression in lung cancer patients: the role of perceived stigma. Psycho-Oncology. 2012;21(3):239–46.CrossRefPubMed
7.
Cataldo JK, Brodsky JL. Lung cancer stigma, anxiety, depression and symptom severity. Oncology. 2013;85(1):33–40.CrossRefPubMed
8.
LoConte NK, Else-Quest NM, Eickhoff J, Hyde J, Schiller JH. Assessment of guilt and shame in patients with non-small-cell lung cancer compared with patients with breast and prostate cancer. Clin Lung Cancer. 2008;9(3):171–8.CrossRefPubMed
9.
Cho J, Choi EK, Kim SY, Shin DW, Cho BL, Kim CH, et al. Association between cancer stigma and depression among cancer survivors: a nationwide survey in Korea. Psycho-Oncology. 2013;22(10):2372–8.PubMed
10.
Danker H, Wollbrück D, Singer S, Fuchs M, Brähler E, Meyer A. Social withdrawal after laryngectomy. Eur Arch Otorhinolaryngol. 2010;267(4):593–600.CrossRefPubMed
11.
Daley EM, Perrin KM, McDermott RJ, Vamos CA, Rayko HL, Packing-Ebuen JL, et al. The psychosocial burden of HPV: a mixed-method study of knowledge, attitudes and behaviors among HPV+ women. J Health Psychol. 2010;15(2):279–90.CrossRefPubMed
12.
Phelan SM, Griffin JM, Jackson GL, Zafar SY, Hellerstedt W, Stahre M, et al. Stigma, perceived blame, self-blame, and depressive symptoms in men with colorectal cancer. Psycho-Oncology. 2013;22(1):65–73.CrossRefPubMed
13.
Weiss J, Yang H, Weiss S, Rigney M, Copeland A, King JC, et al. Stigma, self-blame, and satisfaction with care among patients with lung cancer. J Psychosoc Oncol. 2016; in press
14.
Brown Johnson CG, Brodsky JL, Cataldo JK. Lung cancer stigma, anxiety, depression, and quality of life. J Psychosoc Oncol. 2014;32(1):59–73.CrossRefPubMed
15.
Cataldo JK, Jahan TM, Pongquan VL. Lung cancer stigma, depression, and quality of life among ever and never smokers. Eur J Oncol Nurs. 2012;16(3):264–9.CrossRefPubMed
16.
Cataldo JK, Slaughter R, Jahan TM, Pongquan VL, Hwang WJ. Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale. Oncol Nurs Forum. 2011;38(1):E46–54.CrossRefPubMedPubMedCentral
17.
Chambers SK, Baade P, Youl P, Aitken J, Occhipinti S, Vinod S, et al. Psychological distress and quality of life in lung cancer: the role of health-related stigma, illness appraisals and social constraints. Psycho-Oncology. 2015;24(11):1569–77.CrossRefPubMedPubMedCentral
18.
Arunachalam D, Thirumoorthy A, Devi S. Thennarasu. Quality of life in cancer patients with disfigurement due to cancer and its treatments. Indian J Palliat Care. 2011;17(3):184–90.CrossRefPubMedPubMedCentral
19.
Chambers SK, Dunn J, Occhipinti S, Hughes S, Baade P, Sinclair S, et al. A systematic review of the impact of stigma and nihilism on lung cancer outcomes. BMC Cancer. 2012;12:184.CrossRefPubMedPubMedCentral
20.
Fife BL, Wright ER. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav. 2000;41(1):50–67.CrossRefPubMed
21.
Eichhorn S, Mehnert A, Stephan M. German version of the social impact scale (SIS-D)--pilot testing of an instrument for measuring experienced stigmatization in a sample of cancer patients. Psychother Psychosom Med Psychol. 2015;65(5):183–90.CrossRefPubMed
22.
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRefPubMed
23.
Hinz A, Singer S, Brähler E. European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncol. 2014;53(7):958–65.CrossRefPubMed
24.
Gräfe K, Zipfel S, Herzog W, Löwe B. Screening psychischer Störungen mit dem "Gesundheitsfragebogen für Patienten (PHQ-D)". Ergebnisse der deutschen Validierungsstudie. Diagnostica. 2004;50:171–81.CrossRef
25.
Else-Quest NM, LoConte NK, Schiller JH, Hyde JS. Perceived stigma, self-blame, and adjustment among lung, breast and prostate cancer patients. Psychol Health. 2009;24(8):949–64.CrossRefPubMed
26.
Criswell KR, Owen JE, Thornton AA, Stanton AL. Personal responsibility, regret, and medical stigma among individuals living with lung cancer. J Behav Med. 2016;39(2):241–53.CrossRefPubMed
Metadata
Title
Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients
Authors
J. Ernst
A. Mehnert
A. Dietz
B. Hornemann
P. Esser
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3742-2

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue

Research article

Societal preferences for adjuvant melanoma health states: UK and Australia

Research article

Methodological study to evaluate the psychometric properties of FACIT-CD in a sample of Brazilian women with cervical intraepithelial neoplasia

Research article

Morphological and phenotypical features of ovarian metastases in breast cancer patients

Research article

Cancer mortality in former East and West Germany: a story of unification?

Research article

Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients

Software

GRcalculator: an online tool for calculating and mining dose–response data
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits